Results 111 to 120 of about 6,369 (156)

Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings. [PDF]

BioDrugs
Kvien TK, Betteridge N, Brückmann I, Bodenmüller W, Bryn G, Danese S, Gonçalves J, Maravic Z, Thorne C, Wingate L, Cornes P.   +10 more
europepmc   +1 more source

Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany. [PDF]

Support Care Cancer
Steinmetz T, Jungberg P, Guth D, Knoblich J, Fietz T, Göhler T, Reiser M, Totzke U, Bernhardt K.   +8 more
europepmc   +1 more source

Efficacy and Safety of Pegfilgrastim in Patients With Severe Congenital Neutropenia. [PDF]

EJHaem
Movahedi M, Moradi L, Alizadeh Z, Yazdi MT, Dehbashi S, Shoormasti RS, Maddah M, Razaghian A, Hamidieh AA, Shariat M, Houshmand M, Alirezaee A, Akbari M, Fazlollahi MR, Pourpak Z.   +14 more
europepmc   +1 more source

A Rare Case of Atezolizumab-Induced Very Severe Aplastic Anemia. [PDF]

Cureus
Vadlapatla V, Truong RD, Tseng JE.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Filgrastim

Reactions Weekly, 2022
  +6 more sources

Filgrastim

Reactions Weekly, 2021
  +5 more sources

Filgrastim

Reactions Weekly, 2023
  +4 more sources

Filgrastim

Reactions Weekly, 2015
  +5 more sources

Filgrastim

Reactions Weekly, 1996
  +4 more sources